AHR Insider Valerie Richardson Buys 2,594 Shares

Valerie Richardson acquired 2,594 shares of American Healthcare REIT, Inc. (NYSE:AHR) on June 24, 2026. This transaction follows a series of similar moves by other leaders at the firm on the same day, suggesting a shared interest in the company's equity among its leadership group.

Broad Insider Activity at American Healthcare REIT

The purchase by Richardson was not an isolated event. On June 24, 2026, several other insiders also acquired 2,594 shares each, including Mathieu Streiff, Smith Wilbur III, Marvin O'Quinn, Dianne Hurley, and Brian Flornes. These acquisitions occurred on the same day that Mark Foster, the company's EVP, General Counsel, and Secretary, sold 2,500 shares at a price of $48.58, a transaction valued at $121,450. None of these trades were executed under a Rule 10b5-1 plan, which are pre-scheduled trading arrangements designed to avoid conflicts of interest.

American Healthcare REIT Stock Trends

On Saturday, the stock was trading at $51.48. This price level is slightly higher than the 200-day moving average of $50.88, a common technical indicator used to track long-term trends. The company has a total market valuation of approximately $11.4 billion. While the price is off its recent high of $58.70, it remains well above the $40.00 low seen over the last year.

Recent Earnings and Financial Health

In its most recent financial reports, American Healthcare REIT posted annual revenue of $2.5 billion, representing a growth of 24.7%. The company maintains a net margin of 4.83% and a return on equity of 3.95%. Investors are watching for the next earnings announcement, which is scheduled for November 5, 2026. The company's debt-to-equity ratio sits at 41.89, providing a look at how it balances its obligations against shareholder equity.

Dividend Income Details

For investors focused on steady income, the company pays an annual dividend of $1.00 per share. This results in a dividend yield of 1.92%. The payout ratio is currently 1.47, meaning the company is paying out more in dividends than its current net income, a situation that is common for REITs which are required to distribute the majority of their taxable income to shareholders.

Analysts Set New Price Targets

Wall Street remains optimistic about the REIT's prospects. On October 13, 2026, Raymond James initiated coverage with a Strong Buy rating and a $62.00 price target. On that same day, UBS and Barclays maintained their positive stances, setting price targets of $62.00 and $60.00 respectively. Earlier in the year, Keybanc raised its target to $68.00, and Scotiabank lifted its outlook to $62.00. Across 15 analyst opinions, the consensus recommendation is a Strong Buy, with an average price target of $64.40.

About American Healthcare REIT, Inc.

Based in Irvine, California, American Healthcare REIT focuses on clinical healthcare real estate. The company owns and manages a variety of properties including senior housing, skilled nursing facilities, and medical offices across the United States and the United Kingdom. Its business model relies on generating income from these essential healthcare facilities while selectively developing new properties to grow its portfolio.

What's Ahead for American Healthcare REIT, Inc.

The cluster of insider purchases in June provides a data point for investors to consider alongside the upcoming November earnings report. While these SEC filings show where insiders put their money in the past, they do not guarantee future performance. Market participants will likely watch if the company can sustain its double-digit revenue growth through the end of the year.